Venetoclax dose escalation rapidly activates a BAFF/BCL-2 survival axis in chronic lymphocytic leukemia

Bibliographic Details
Title:	Venetoclax dose escalation rapidly activates a BAFF/BCL-2 survival axis in chronic lymphocytic leukemia
Authors:	Luo, Meng-Xiao ^{1, 2}, Tan, Tania ^{1, 2}, Trussart, Marie ^{1, 2}, Poch, Annika ^{2, 3}, Nguyen, Thi Minh Hanh ^{2, 3}, Speed, Terence P. ^{1, 2}, Hicks, Damien G. ⁴, Bandala-Sanchez, Esther ^{1, 2}, Peng, Hongke ^{1, 2}, Chappaz, Stéphane ⁵, Slade, Charlotte ^{1, 2}, Utzschneider, Daniel T. ^{2, 3}, Koldej, Rachel M. ^{2, 6}, Ritchie, David ^{2, 6, 7}, Strasser, Andreas ^{1, 2}, Thijssen, Rachel ^{1, 2}, Ritchie, Matthew E. ^{1, 2}, Tam, Constantine S. ^{5, 8}, Lindeman, Geoffrey J. ^{1, 2, 9}, Huang, David C. S. ^{1, 2}, Lew, Thomas E. ^{1, 2, 7, 9}, Anderson, Mary Ann ^{1, 2, 7, 9}, Roberts, Andrew W. ^{1, 2, 7, 9}, Teh, Charis E. ^{1, 2, ∗}, Gray, Daniel H. D. ^{1, 2, ∗∗}
Source:	In Blood 26 December 2024 144(26):2748-2761
Database:	ScienceDirect

Be the first to leave a comment!